Structure Therapeutics Inc. (GPCR) Stock News & Chart | StockAdder

(GPCR)

Structure Therapeutics Inc.

Stock chart and latest news for Structure Therapeutics Inc., tracked under Pharmaceuticals, Biotechnology & Life Sciences in the Health Care sector.

Chart powered byTradingView— professional charts for every trader.Try it free →

Structure Therapeutics Inc. News

PRO

Metsera legal chief joins Structure as COO ahead of Phase 3

Apr 14, 2026 Yahoo Finance

Assessing Structure Therapeutics (GPCR) Valuation After Recent Share Price Weakness

Apr 9, 2026 Seeking Alpha

Structure Therapeutics: A High-Risk, High-Reward Bet On The Next GLP-1 Blockbuster (GPCR)

Mar 27, 2026 simplywall.st

Why Structure Therapeutics (GPCR) Is Up 21.7% After Promising Phase 2 Oral Obesity Drug Data

Apr 6, 2026 Yahoo Finance

Structure Therapeutics (GPCR) Gained from Favorable Clinical Data

Feb 19, 2026 Seeking Alpha

Structure Therapeutics: The Oral Obesity Inflection, Best-In-Class Efficacy Meets Biased-Agonism Safety Moat

Apr 8, 2026 Stock Titan

Structure Therapeutics (NASDAQ: GPCR) awards new options and RSUs

Mar 23, 2026 simplywall.st

Assessing Structure Therapeutics (GPCR) Valuation After Recent Share Price Volatility

Mar 21, 2026 Yahoo Finance

Structure Therapeutics Inc. (GPCR) Has Gained Over 130% in 3 Months. Here is Why

Jan 15, 2026 Stock Titan

Pill from Structure Therapeutics helped patients lose about 40 lbs

Mar 16, 2026 Yahoo Finance

Why Structure Therapeutics (GPCR) Is Up 23.2% After Aleniglipron Milestone And $748 Million Raise – And What's Next

Jan 14, 2026 Stock Titan

Structure Therapeutics (GPCR) CFO receives large option and RSU grants